首页> 外国专利> APTAMERS AND SENSING TECHNOLOGY USED FOR DETECTION OF GLYCATED HEMOGLOBIN IN WHOLE BLOOD

APTAMERS AND SENSING TECHNOLOGY USED FOR DETECTION OF GLYCATED HEMOGLOBIN IN WHOLE BLOOD

机译:用于检测全血中糖化血红蛋白的适体和传感技术

摘要

High affinity DNA aptamers Seq ID#1-8 for HbA1C and tHb were successfully selected using SELEX after 11 rounds of selection. The tested aptamers bind to HbA1C with dissociation constants in the nanomolar range with the highest affinity aptamer, Seq ID#6, exhibiting a Kd of 2.8 nM. Another aptamer sequence (Seq ID #4) which showed high binding affinity to tHb with a Kd of 2.7 nM was also selected. The HbA1C and tHb-specific aptamers were then applied for the detection of HbA1C % using a voltammetric aptasensor array platform showing remarkable sensitivity and selectivity. The aptasensor array platform was validated using standard human whole blood samples and demonstrated linearity over wide concentration range. The developed platform is superior to current methodologies due to its simplicity, stability and lower cost which will facilitate the early and accurate diagnosis of diabetes.
机译:经过11轮选择后,使用SELEX成功选择了HbA1C和tHb的高亲和力DNA适体Seq ID#1-8。被测试的适体以纳摩尔摩尔范围的解离常数与HbA1C结合,具有最高的亲和力适体Seq ID#6,其K d 为2.8 nM。还选择了另一个适配子序列(Seq ID#4),该适配子序列显示对tHb具有高结合亲和力,K d 为2.7 nM。然后使用伏安适体传感器阵列平台,将HbA1C和tHb特异性适体用于HbA1C%的检测,显示出显着的灵敏度和选择性。 aptasensor阵列平台已使用标准的人类全血样本进行了验证,并在很宽的浓度范围内表现出线性。由于其简单性,稳定性和较低的成本,开发的平台优于当前的方法,这将有助于糖尿病的早期和准确诊断。

著录项

  • 公开/公告号US2018031578A1

    专利类型

  • 公开/公告日2018-02-01

    原文格式PDF

  • 申请/专利权人 SHIMAA EISSA;MOHAMMED ZOUROB;

    申请/专利号US201615223202

  • 发明设计人 SHIMAA EISSA;MOHAMMED ZOUROB;

    申请日2016-07-29

  • 分类号G01N33/72;C12N15/115;G01N33/53;

  • 国家 US

  • 入库时间 2022-08-21 13:00:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号